Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...
Xenon Pharmaceuticals (XENE) is undervalued given azetukalner's late-stage potential to transform epilepsy and mood disorder ...
According to the Texas Department of State Health Services, the Texas Poison Center Network logged 192 reports that year ...
I went on for about 2 months due to my mental health. I was unable to do my job and kept making mistakes and was in a very dark place. Matrix kept losing paperwork and made the process as complicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback